Crossmark

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study

Published Online: 2021-01-03

Published Print: 2021-02

Authors

Kudo, Masatoshi https://orcid.org/0000-0002-4102-3474
Tsuchiya, Kaoru

Kato, Naoya

Hagihara, Atsushi

Numata, Kazushi

Aikata, Hiroshi

Inaba, Yoshitaka

Kondo, Shunsuke

Motomura, Kenta

Furuse, Junji

Ikeda, Masafumi

Morimoto, Manabu

Achira, Meguru

Kuroda, Shingo

Kimura, Akiko
License Information

Text and Data Mining valid from 2021-01-03

Version of Record valid from 2021-01-03
More Information

Article History

Received: 26 May 2020

Accepted: 18 November 2020

First Online: 3 January 2021

Document is current